November 14, 2017 / 4:12 PM / a month ago

BRIEF-STEADYMED RECEIVES FAVORABLE RULING FROM U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT

Nov 14 (Reuters) - Steadymed Ltd:

* ‍COURT OF APPEALS AFFIRMED A MARCH 31 RULING BY PATENT TRIAL & APPEAL BOARD INVALIDATING U.S. PATENT NO 8,497,393 OWNED BY UNITED THERAPEUTICS​

* ‍INVALIDITY DECISION WILL PRECLUDE UNITED THERAPEUTICS FROM ASSERTING ‘393 PATENT PRIOR TO STEADYMED‘S LAUNCH OF ITS TREVYENT PRODUCT​

* ‍FDA REGULATIONS REQUIRE THAT UNITED THERAPEUTICS “PROMPTLY NOTIFY FDA TO…WITHDRAW PATENT” FROM FDA‘S “ORANGE BOOK.”​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below